New Leaf Venture Partners LLC - Assets, Funds, Holdings
New Leaf Venture Partners LLC
CRD # 163897
SEC # 801-80793
CIK # 0001631614
AUM
408.4 M (2026-03-30)
Employees
4 (50% Investors, 0% Brokers)
Fees
Minimum
Phone 646-871-6420
Address 156 Fifth Avenue New York, NY 10010
Source
[IAPD]
[EDGAR]
[Website] [Twitter] [LinkedIn]
Total AUM ($M)
1100 880 660 440 220 0 2010 2015 2021 2027
Holdings by Sector ($M)
600 480 360 240 120 0 2013 2017 2021 2026
Type
Form D Funds
Date
Sold
AUM
VC
NLV Co-Invest IV LP
[2025-03-31]
16.7 M
16.8 M
Offered $16,660,000 · Filed 2024-12-31 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable
VC
NLV-II SPV-1 LP
[2024-03-28]
90.8 M
VC
NLV-II SPV-2 LP
[2024-03-28]
9.0 M
Filed 2023-11-13 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Not Applicable
VC
NLV Co-Invest III LLC
2022-03-30
9.0 M
VC
NLV Co-Invest II LLC
2021-03-25
5.3 M
VC
New Leaf Biopharma Opportunities II LP
[2019-03-29]
120.7 M
Offered $200,000,000 · Filed 2018-04-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $200,000,000 · Duration One year or less · Revenue Not Applicable
VC
New Leaf Ventures IV LP
[2019-03-29]
94.4 M
Offered $275,000,000 · Filed 2018-04-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $275,000,000 · Duration One year or less · Finder's Fee $25,000 · Revenue Not Applicable
VC
New Leaf Biopharma Opportunities I LP
[2014-12-19]
10.0 M
Offered $200,000,000 · Filed 2014-12-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $200,000,000 · Duration One year or less · Revenue Not Applicable
VC
New Leaf Ventures III LP
[2014-12-19]
62.4 M
Offered $375,000,000 · Filed 2014-12-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $375,000,000 · Duration One year or less · Revenue Not Applicable
VC
NLV Partners Co-Invest I LLC
2014-12-19
8.0 M
View All
AUM Breakdown
Accounts
AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals)
0
0.0
(b) Individuals (high net worth individuals)
0
0.0
(c) Banking or thrift institutions
0
0.0
(d) Investment companies
0
0.0
(e) Business development companies
0
0.0
(f) Pooled investment vehicles
9
408.4
(g) Pension and profit sharing plans
0
0.0
(h) Charitable organizations
0
0.0
(i) State or municipal government entities
0
0.0
(j) Other investment advisers
0
0.0
(k) Insurance companies
0
0.0
(l) Sovereign wealth funds and foreign official institutions
0
0.0
(m) Corporations or other businesses not listed above
0
0.0
(n) Other
0
0.0
Total
9
408.4
By Discretionary
Discretionary
9
408.4
Non-Discretionary
0
0.0
Total
9
408.4
By Non-United States Persons
Non-United States Persons
0.0
United States Persons
408.4
Total
9
408.4
Firm Profile (Form ADV)
Serves Institutional
Fund Types Private Equity
Insider Transaction (Form 3/4/5)
Date
Action
Shares
Price
Value ($)
PDS Biotechnology Corp EDGE
Stock Option (right to purchase) · derivative
2016-06-21
Grant
30,000
$0.00
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}
{"uid": 244294016, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
362793123